Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TroVax: Phase I/II results; Phase II

In a Phase I/II trial in 5 patients, intradermal delivery of TroVax was

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE